Table 1.
MAS (n = 17) | Control (n = 53) | |
---|---|---|
Age | ||
Mean ± SD (range) | 7.44 ± 4.4 (1–17) | 6.6 ± 3.93 (1–17) |
Gender | ||
Male | 10 (58.8%) | 38 (71.7%) |
Female | 7 (41.2%) | 15 (28.3%) |
Diagnosis | ||
SJIA | 10 (58.8%) | 31 (58.3%) |
PJIA | 4 (23.5%) | 12 (22.6%) |
Kawasaki | 2 (11.8%) | 6 (11.3%) |
SLE | 1 (5.9%) | 4 (7.5%) |
Presentation | ||
First presentation | 9 (52.9%) | 31 (58.5%) |
On background illness | 8 (47.1%) | 22 (41.5%) |
MAS: Macrophage Activation Syndrome, SD: standard deviation, SJIA: systemic onset juvenile idiopathic arthritis, PJIA: polyarticular juvenile idiopathic arthritis, and SLE: systemic lupus erythematosus.